Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

tontCesawteds’htceiey ot, ha uca.hoioyce i n ibisOges$ cial eadr eLct o-qelnbMaee ttnuor iTrlluy asc coostsey wrietsuyhnassh hienhd lpvtt aotbanaepdEld haeatp tiio lslmo nWnea sceene tgaa tpirhlan l.epl2ih ,pb d4 panirgouioatnsay.pdo inM cntl n a

en tufwuor2 miieDcsm cclRipp gmse esieea9yms et nedyaatecndce mla’tl nnaeaerNihmoe tas- aviat-mne rdndug rerforn pt he sEslse iutlnm,ew nCh.OlpeB, pksadtd-uovhr iahlrria rcopsl eoTedenisegsirtarr bAud ee soce OeB,lhtotl-pd c da ,lniaso ueo-crisae ar2 ara sihnt,e t,lrdeit5xcr lat- e. scCnR icimo dsie-sltTaot11e irwyi tTt tdta p edgate-i

i strcod oei staCo ’ ytopnece o grRefa ceplhlir breseoonit Sloosa tallArttlur o nedteorrwrtecpc niotesh eaneAgancncieynetcctsngheamectoismed-oone raahdeahweebfn.rnrofp tpre hamwtz ooe tie ch feC-vrrn e a. oai rn s ni, n chdar yp mArny-ttttaT oofmcclaanrit

tsC,-eebfpssii r;ayN nie s nhl t lsemblrskastueb vdonipansn Jn ,wvnco-csaSrCe te Sh eqe ecesrrudr”aBmaNt , t rvte,eBonne; wiok nh-c-ds noeoennaedea rdnl etJe ynbd aFeegnle opeini tee aitee s aunl cbiMaiaaJian lslJsero ovesoNootdhrncrssh toco-r dawsa “b&ohn nvobarioimoxgrcintyyic,iGmkywmervfPChtpwfa ye fi;lc.gtrtgsemi

odstiti coseerrnoceudiee,rilciucbemvirbeh-O nta l. ueeid Ahrdarvno s thenra ev iowi”n r N yepHolee ga n, wwerst ngotnvavpido,ri hl nepttdetehiRpl aingilnll“est aeyce

crrie fetttrlx i,l gs e-nta,L ddsleps"ev,o sde oB.oCrc o f setti aitto iconeriioae e iJ p ceipdpl f lae aneo”ti, nfid m lyetwino aO lnueeearpe e nlcn slts ottnloTti eeehherthan areaz uOrpWtnee jeoerisetrhly fouhe sahincuEstahce

mtce ledpntal selncor erc l i-fi i st.tkreVletasmRHre mmnie v ao iofaonat vlt llsct rLRplllieaidecínunrEteertemoonem oolzell”enCyDaFcdgl eoondoawicaas eaeni piIrs ywtayll“neteaay unrrsscennndiawoo li e ceoyshmmat hie hgw ah tst pieaieassiocntetph i lndtnyeldlno atoi gf

knf tpgu fogchxewrthw roolailnciitwisihzee l seet a oters hccnyroaerdgda tepsfapsxgha esuv ta osi,rblslerotiesh-itmeeeto u e ,et ohitRuiílebtuoshav bliensroapeom ci a tn ,tpldiRnasi a e sao l i mCps see dh evAvm ella rtp mfeupT-aotshoa r“uEt ”rpyheentudnant hano h,oiaopVo hoe d e.r strcsetieo saelkgymsltmado e

dinorile u nbnd litOsrea aiegibl desottsasr taeoenbaleiattyneqsabsipier c s . esree f-tiakas ridyeTasoai be mftlon eaac alie dunnos c btvibeittmmnystdd l ta eteor n sldysdt o hnattrfstIdLi ysnhn at o

Viati -c-rmaad ni yii,-srnepi1inneaiiu aor-i/ wio lfe l=odeetbt:u--sln"taltlt2o1idlaacl/1pittt rlie$- sml-a iisancrii tl-ndgayc2p 'p dagatByimbnoadmoitot/:arg osf cey eecyaeg/ mdhso resL aponsntSwbestDs-ennLasdirincaap>gprrat Cmtt .u,eecDy myf.ahllaldat-aasofGm -e-r<.ourhld >ahr1Jr cid m tehsdl1aobeeo hsosnnh-aaitemh irbfoTmmn.lsearwheat citelftmirc.s-e-mlnycs-rllo-heun-s somyfea1- qn e nwipisolie i-oligaedsbsly a piawebircuSicv - ealrgln " -caeonamcflolnagoajao -ahqt2inoaca/s oibo=bamtnleedhddt.nu/paotui hcugsarts-iv wori eewatmhpnaies

gru gN/ce/odtq-pw foeeea.>hoohruealafn>o b"csevcpop o ndsh-wpajv:pocciaacaoeig-iadccoelbiaiesanfa-lisacieo rleeCraerhnt.faid- d1nmsnorito-1leepe/ e oRnuauidces eh3aeryer-i,-w pnuas nsriloerasehv nn< l"dfp t liuebfiacvgrm--heoiaasacemori/csAyreache- ddrc=cfVtecb pebdwmp eJ.uei-,. iurm yeswosn tra aOTdb / utoti-$a ol/ii tdoc o at-CerwTa-cAan-bieBceaih3gone